跳至主要内容
临床试验/IRCT2013030412699N1
IRCT2013030412699N1已完成2 期

Effect of Bromocriptin on insulin resistance in comparison with placebo in patients with polycystic ovaries referring to Golestan Hospital of Ahvaz.

Vice Chancellor for Development, Research and Technology of Ahvaz Jondishapour University of Medical0 个研究点目标入组 44 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 45 years(—)
性别
Female

入选标准

  • Patients with polycystic ovaries between 16 and 45 years old and Body Mass Index (BMI) more than 25. Exclusion criteria: Fasting blood sugar more than 126, hypothyroidism, prolactinoma, nonclassic congenital adrenal hyperplasia, psychosis, breast feeding, syncope attack, severe nausea and vomiting.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Development, Research and Technology of Ahvaz Jondishapour University of Medical

相似试验